121
TITLE: MANAGEMENT OF SYMPTOM RE-EMERGENCE IN PATIENTS LIVING WITH SPASTICITY AND CERVICAL DYSTONIA: FINDINGS FROM 2 ONLINE PATIENT SURVEYS  Full Text
AUTHORS: Esquenazi, A; Ferreira, JJ ; Jacinto, J; Lysandropoulos, A; Comella, C;
PUBLISHED: 2021, SOURCE: TOXINS Conference on Basic Science and Clinical Aspects of Botulinum and other Neurotoxins in TOXICON, VOLUME: 190
INDEXED IN: WOS
122
TITLE: miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson's Disease
AUTHORS: Oliveira, SR; Dionísio, PA; Gaspar, MM ; Guedes, LC; Coelho, M; Rosa, MM; Ferreira, JJ ; Amaral, JD; Rodrigues, CMP ;
PUBLISHED: 2021, SOURCE: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, VOLUME: 9
INDEXED IN: Scopus WOS CrossRef: 18
123
TITLE: Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses
AUTHORS: van Munster, M; Stumpel, J; Thieken, F; Pedrosa, DJ; Antonini, A; Cote, D; Fabbri, M; Ferreira, JJ ; Ruzicka, E; Grimes, D; Mestre, TA;
PUBLISHED: 2021, SOURCE: JOURNAL OF PERSONALIZED MEDICINE, VOLUME: 11, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 20
124
TITLE: Neuroimaging cerebrovascular biomarkers in Parkinson's disease
AUTHORS: Alves, M; Lobo, PP; Kauppila, LA; Rebordao, L; Cruz, MM; Guerreiro, C; Ferro, JM; Ferreira, JJ ; Reimao, S;
PUBLISHED: 2021, SOURCE: NEURORADIOLOGY JOURNAL, VOLUME: 35, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 1
125
TITLE: Parkinson's Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
AUTHORS: Boucherie, DM; Duarte, GS; Machado, T; Faustino, PR; Sampaio, C; Rascol, O; Ferreira, JJ ;
PUBLISHED: 2021, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 11, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 7
126
TITLE: PATIENT EXPERIENCES OF SYMPTOM RE-EMERGENCE: FINDINGS FROM 2 ONLINE PATIENT SURVEYS IN SPASTICITY AND CERVICAL DYSTONIA  Full Text
AUTHORS: Esquenazi, A; Jacinto, J; Ferreira, JJ ; Lysandropoulos, A; Comella, C;
PUBLISHED: 2021, SOURCE: TOXINS Conference on Basic Science and Clinical Aspects of Botulinum and other Neurotoxins in TOXICON, VOLUME: 190
INDEXED IN: WOS
127
TITLE: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia (vol 268, pg 903, 2020)  Full Text
AUTHORS: Comella, C; Ferreira, JJ ; Pain, E; Azoulai, M; Om, S;
PUBLISHED: 2021, SOURCE: JOURNAL OF NEUROLOGY, VOLUME: 268, ISSUE: 3
INDEXED IN: WOS
128
TITLE: Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
AUTHORS: Antunes, MM; Duarte, GS; Brito, D; Borges, M; Costa, J; Ferreira, JJ ; Pinto, FJ ; Caldeira, D;
PUBLISHED: 2021, SOURCE: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, VOLUME: 7, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 23
129
TITLE: Potential drug-drug interactions in acute poisonings managed in the intensive care unit: Occurrence, risk factors and relationship to patient severity on admission
AUTHORS: Mainoli, B; Goncalves, N; Ferreira, JJ ; Megarbane, B;
PUBLISHED: 2021, SOURCE: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, VOLUME: 130, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 3
130
TITLE: Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone
AUTHORS: Jenner, P; Rocha, JF; Ferreira, JJ ; Rascol, O; Soares da Silva, P;
PUBLISHED: 2021, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 21, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 19
Page 13 of 70. Total results: 700.